Statins can trigger apoptosis of prostate cancer cells through HMG-CoA reductase inhibition [5], and prostate cancer patients receiving neoadjuvant statin therapy prior to prostatectomy demonstrated reduced tumor proliferation and increased apoptosis in the surgical prostate specimen [6,7]. Here, HMGCR is linked to prostate carcinoma.